[vc_row][vc_column][vc_column_text]Dr. Stuart Titus, the CEO of Medical Marijuana, Inc., was interviewed recently as part of a story on UOL News in Brazil regarding the effects of medical cannabis on patients with Parkinson’s disease. The story featured a video of a man that had gone viral showing a rapid improvement in his Parkinson’s symptoms after taking a single treatment of medical cannabis.
Quotes from Dr. Titus served to act as a counter-balance to a skeptical neurologist in the story, Rogerio Tuma, who insists that there isn’t enough evidence to prove that cannabis has benefit for Parkinson’s disease. Dr. Titus reveals in the story that cannabinoids like cannabidiol show promise for neurodegenerative diseases like Parkinson’s.
“We have seen evidence that cannabidiol acts as a neuro-protector and, therefore, can help patients,” Titus remarks in the piece.
The UOL News story focused on an American patient, Larry Smith, who has been living with Parkinson’s disease for the past twenty years. Smith turned to medical cannabis as an option after exhausting all conventional treatments, including brain surgery. Smith had a device similar to a pacemaker that creates an electrical stimulus implanted into his brain.
However, Smith claims it is the medical cannabis that has helped him the most. His story is intended to become a documentary that will reveal his struggles and triumph, ending with Smith participating in a bike race – a feat unthinkable before medical cannabis. [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_single_image image=”17365″ img_size=”1200×250″ onclick=”custom_link” link=”https://www.medicalmarijuanainc.com/overview-of-medical-marijuana-research/”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]While Tuma remains unconvinced, Dr. Titus insists that evidence is mounting in favor of cannabis. Medical Marijuana, Inc. tracks users of medical marijuana patients in Brazil to record their experiences and the efficacy of their treatments.
“We really hope we have more scientific evidence for physicians to evaluate how cannabidiol can positively impact Parkinson’s patients. We collect data from patients who use it,” says Titus of the work Medical Marijuana, Inc. has done in Brazil. “We have patients who confirm a relatively rapid recovery from the tremors.”
The medical use of marijuana, specifically CBD, in Brazil began in the spring of 2015, when the first cannabis-based products were introduced into the country. Since then, the health authority in Brazil, ANVISA, has begun considering approval of medical cannabis on a case-by-case basis.
“Cannabidiol may be prescribed for Parkinson’s, but the patient needs to be prescribed ANVISA’s medical prescription and approval to get the drug,” said Titus as he described the process to access medical marijuana in Brazil.
Medical Marijuana, Inc. is dedicated to increasing access to the benefits of cannabis and cannabinoids all over the world through the work of our family of investment companies. Read more about developments within the cannabis industry on our news feed. [/vc_column_text][/vc_column][/vc_row]
